QIAGEN powered by
Unveiling CLC Genomics Cloud Engine at Bio IT

QIAGEN Digital Insights Monday, May 8, 2017

We’re thrilled to announce that we’ll be unveiling the newest addition to our bioinformatics portfolio – CLC Genomics Cloud Engine –…

ESHG 50th Anniversary

QIAGEN Digital Insights Tuesday, May 2, 2017

This year ESHG is celebrating it’s 50th anniversary in beautiful Copenhagen! Come and meet us at booths 540 and 542 and…

Essential for NGS data annotation

QIAGEN Digital Insights Tuesday, April 4, 2017

Now with more than 200,000 Mutation Reports, and improvements to help assess pathogenicity, HGMD is confirmed as the essential tool…

Join us at ACMG 2017 in Phoenix

QIAGEN Digital Insights Tuesday, March 7, 2017

Meet us at ACMG 2017 The American College of Medical Genetics and Genomics Annual Meeting (ACMG 2017) takes place on…

Improve your data analysis experience with our new releases

QIAGEN Digital Insights Thursday, March 2, 2017

We’re happy to announce that new releases of our products are now available. These releases offer a number of new features and improvements. You can…

Potential targeted therapies for cervical cancer

QIAGEN Digital Insights Thursday, March 2, 2017

We were pleased to see this Oncotarget report includes our software CLC Genomics Workbench as an important tool in identifying and characterizing cervical…

Supporting Rare Disease Day 2017

QIAGEN Digital Insights Friday, February 24, 2017

Research to beat rare diseases With Rare Disease Day 2017 approaching on February 28, we want to show our support. As…

Attending HIMSS17?

QIAGEN Digital Insights Tuesday, February 14, 2017

This year at HIMSS17 We’ll be joining Intel in their booth #2661 to share insights on NGS-based genetic testing across a range…

Clinical oncology testing

QIAGEN Digital Insights Tuesday, January 31, 2017

QCI Interpret’s integration of highly curated knowledge and rules enables automation for much of the interpretation and reporting process for…

Tackling Cancer Cohorts

QIAGEN Digital Insights Tuesday, January 24, 2017

Research scientist Dr. Margarete Odenthal leads the translational molecular pathology group at University Hospital Cologne, putting new technologies through their…

Rare Genomics Institute: Solving rare disease mysteries

QIAGEN Digital Insights Friday, January 6, 2017

Nearly 250 million people around the world are affected by rare diseases, which are typically genetic in nature. Their rarity…

Highlights from London

QIAGEN Digital Insights Thursday, November 24, 2016

Not too long ago, we returned from Oxford Global’s 8th Annual NGS Congress. While the majestic host city of London was…